Fernando Ramos

3.7k total citations
68 papers, 1.5k citations indexed

About

Fernando Ramos is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Fernando Ramos has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 20 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Fernando Ramos's work include Acute Myeloid Leukemia Research (47 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (13 papers). Fernando Ramos is often cited by papers focused on Acute Myeloid Leukemia Research (47 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (13 papers). Fernando Ramos collaborates with scholars based in Spain, United Kingdom and France. Fernando Ramos's co-authors include Jesús F. San Miguel, Marcos González, António Almeida, María‐Belén Vídriales, María José Calmuntia, C López-Berges, Alberto Órfão, Consuelo del Cañizo, Norma C. Gutiérrez and Javier Fernández‐Calvo and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Fernando Ramos

64 papers receiving 1.5k citations

Peers

Fernando Ramos
Comparison fields: 5 of 67
  • Hematology 1.2k
  • Molecular Biology 524
  • Public Health, Environmental and Occupational Health 445
  • Genetics 347
  • Oncology 201
Pascale Lepelley France
Anne Marie Stoppa France
C López-Berges Spain
Po Dunn Taiwan
Abhishek Maiti United States
Thomas Nösslinger Austria
Athanasios Zomas Greece
Otto Krieger Austria
M. L. Vegna Italy
Emma Das‐Gupta United Kingdom
Pascale Lepelley France View profile →
Citations per field, relative to Fernando Ramos
Fernando Ramos · 1×
Citations per year, relative to Fernando Ramos
Fernando Ramos · 1×

Countries citing papers authored by Fernando Ramos

Since Specialization
Citations

This map shows the geographic impact of Fernando Ramos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Ramos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Ramos more than expected).

Fields of papers citing papers by Fernando Ramos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Ramos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Ramos. The network helps show where Fernando Ramos may publish in the future.

Co-authorship network of co-authors of Fernando Ramos

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Ramos. A scholar is included among the top collaborators of Fernando Ramos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Ramos. Fernando Ramos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes Therapeutic Advances in Hematology Julio Dávila, Maria López‐Pavía et al. 3
2 Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice Journal of Personalized Medicine Fernando Ramos, Pilar Martı́nez et al. 1
3 Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma Supportive Care in Cancer Pere Gascón, Reyes Arranz et al. 8
4 A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts Leukemia Research Kamila Janusz, Mónica Del Rey et al. 3
5 Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis Annals of Hematology María Julia Montoro, Cristina Robledo et al. 2
6 Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes Modern Pathology Xavier Calvo, Leonor Arenillas et al. 6
7 Infección pulmonar por Nocardia farcinica en un paciente con fibrosis quística y trasplante pulmonar Revista Española de Anestesiología y Reanimación Romeu Vicente, Fernando Ramos et al. 2
8 Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León Medicina Clínica Lourdes Vázquez, Fernando Ramos et al. 0
9 Oxigenación con membrana extracorpórea en la disfunción primaria del injerto en trasplante bipulmonar pediátrico: a propósito de un caso Revista Española de Anestesiología y Reanimación Romeu Vicente, Fernando Ramos et al. 1
10 High incidence of acute leukemia in the proximity of some industrial facilities in El Bierzo, northwestern Spain International Journal of Occupational Medicine and Environmental Health Fernando Ramos et al. 3
11 Oxigenador de membrana extracorpóreo en el trasplante pulmonar Medicina Intensiva Romeu Vicente, Fernando Ramos et al. 4
12 Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival Annals of Hematology Carlos Santamaría, Fernando Ramos et al. 12
13 The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome Leukemia Research José Ramón González‐Porras, Esperanza Such et al. 17
14 BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML) Annals of Hematology Carlos Santamaría, Carmen Chillón et al. 35
15 Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11 Cancer Genetics and Cytogenetics Magdalena Sierra, Jesús María Hernández‐Rivas et al. 6
16 Cardiopulmonary transplantation: experience of a lung transplant group Transplantation Proceedings P. Morales, Luís Almenar et al. 3
17 Dyshaemopoietic bone marrow features in healthy subjects are related to age Leukemia Research Fernando Ramos et al. 3
18 [Lung transplantation in cystic fibrosis. The results of the Clínica Puerta de Hierro (Madrid) and the Hospital La Fe (Valencia)]. PubMed P. Morales, A. Varela et al. 2
19 Characterization of aberrant phenotypes in acute myeloblastic leukemia Annals of Hematology Antônio Vaz de Macedo, Alberto Órfão et al. 73
20 Characterization of aberrant phenotypes in acute myeloblastic leukemia Annals of Hematology Antônio Vaz de Macedo, María‐Belén Vídriales et al. 7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026